ArticleFrontiers in oncology2026
Contrast clearance analysis in post-operative brain metastases resection cavities: case series and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aims of this study were to assess how previously described treatment response assessment maps/contrast clearance analysis (TRAMs/CCA) imaging appearances may present in post-operative brain metastasis resection cavities and to discuss their potential contribution to clinical decision-making. Methods: This retrospective descriptive case series included four patients with surgically resected brain metastases. Cases were purposively selected to illustrate distinct post-operative TRAMs/CCA imaging appearances resembling those previously described after stereotactic radiosurgery (SRS). All included patients had histologically confirmed metastatic disease and underwent routine post-operative magnetic resonance imaging (MRI) surveillance. TRAMs/CCA imaging was performed using a 1.5-T MRI scanner according to the Brainlab Elements protocol for CCA with standard-dose gadolinium administration. Early and delayed post-contrast 3D T1-weighted sequences were analyzed to generate contrast clearance maps, providing complementary imaging information regarding contrast enhancement characteristics of post-operative lesions. Post-operative cavities were assessed in multidisciplinary consensus. Results: Four representative CCA/TRAMs imaging appearances within post-operative resection cavities, showing features analogous to TRAMs/CCA imaging features previously described after SRS, were observed and correlated with conventional contrast-enhanced T1-weighted MRI findings and follow-up outcomes. Appearances characterized by the absence of early contrast clearance or by extensive persistent delayed retention despite marked contrast enhancement were observed in cases with post-operative changes without local recurrence; in these cases, adjuvant SRS was deferred and MRI surveillance was performed. Mixed TRAMs/CCA appearances with focal areas of early contrast clearance were observed in a case that subsequently developed local recurrence within regions considered suspicious on TRAMs/CCA. In contrast, appearance characterized by a thin peripheral early contrast clearance with adjacent delayed contrast retention was observed in a case with intermediate post-operative findings for which follow-up imaging was not available. Conclusions: TRAMs/CCA may represent a useful non-invasive adjunct to conventional MRI for SRS planning after brain metastases resection. These findings support further investigation of TRAMs/CCA as a potential adjunct for treatment planning and longitudinal surveillance. Further prospective studies are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.